Search results
Campaign fuels efforts to find better treatments for blood cancers in children
NBC Dallas Fort Worth· 9 hours agoLeukemia and Lymphoma Society's (LLS) Dare to Dream project hopes to raise money for research of...
EHA 2024: Odronextamab shows promise in ELM-2 study for follicular lymphoma
Clinical Trials Arena via Yahoo Finance· 2 days agoFollicular lymphoma (FL) is a chronic disease that accounts for about 20% of non-Hodgkin's lymphoma...
New Clues to Origin of T-Cell Lymphoma After CAR-T Therapy
MedPage Today· 7 days agoOnly one of 724 patients treated with chimeric antigen receptor (CAR) T-cell therapy for B-cell ...
Reliable Subaru and The Leukemia & Lymphoma Society donate blankets to cancer patients
Springfield News-Leader via Yahoo News· 4 days agoReliable Subaru partnered with The Leukemia & Lymphoma Society to support patients facing cancer at...
...Study Demonstrates Columvi Significantly Extends Survival in People With Relapsed or Refractory...
Morningstar· 4 days agoGenentech’s Phase III STARGLO Study Demonstrates Columvi Significantly Extends Survival in People With Relapsed or Refractory Diffuse Large B-cell Lymphoma – The study met ...
AstraZeneca reports positive data from Phase III mantle cell lymphoma trial
Clinical Trials Arena via Yahoo Finance· 2 days agoAstraZeneca Oncology R&D executive vice-president Susan Galbraith said: “The ECHO trial data...
Rapid test of cerebrospinal fluid found to decrease time to diagnosis for brain tumors
Medical Xpress· 15 hours agoThe team evaluated the technique known as TetRS (Targeted Rapid Sequencing) among 70 patients...
Regeneron (REGN) Outperforms Industry YTD: What Lies Ahead?
Zacks via Yahoo Finance· 10 hours agoThe FDA, however, issued complete response letters (CRLs) for its BLA for odronextamab. The BLA is...
Brigatinib Makes Its Case for ALK-Positive ALCL in Small Study
MedPage Today· 7 days agoAn anaplastic lymphoma kinase (ALK)-targeted agent induced high response rates for adults with...
Three-Drug Regimen Shows OS Benefit in Third-Line DLBCL
MedPage Today· 2 days agoLoretta Nastoupil, MD, leads a discussion on the ECHELON-3 trial results